Researchers develop innovative nanoparticle treatment for pancreatic cancer, targeting the disease more effectively and reducing side effects. Treatment method delivers the drug Gemcitabine directly into tumors, enhancing efficacy and overcoming tumor resistance. Interdisciplinary team focused on advancing this promising therapy into clinical practice for pancreatic cancer patients.